Abstract: The present invention relates to a stent which is inserted into a stenosed bile duct to enlarge the bile duct. The stent includes a plurality of hooks which extend outwards from the main body of the stent at a predetermined angle and are spaced apart from each other. Therefore, when the stent is inserted into the bile duct, the hooks that extend outwards from the main body at a predetermined angle are hooked to the inner surface of the bile duct, thus preventing the stent from slipping relative to the bile duct.

Abstract: Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within Schlemm's canal and maintains the patency of the canal without substantially interfering with transmural fluid flow across the canal. The devices utilize the natural drainage process of the eye and can be implanted with minimal trauma to the eye. Kits include a support and an introducer for implanting the support within Schlemm's canal. Methods include implanting a support within Schlemm's canal, wherein the support is capable of maintaining the patency of the canal without substantial interference with transmural fluid flow across the canal.

Abstract: A mechanically deployable upper airway stent is disclosed along with a method of using same. The stent comprises a central tube having an inner chamber and openings on its surface. A linkage rod is housed within the central tube and is provided with branched spokes that pass through the openings. In the un-deployed state the branched spokes are contained within the central tube. Deployed spokes are preferably aligned in groupings along the central tube. The outer ends of the spokes of each grouping connect to a rib. The un-deployed stent is inserted into the nasal passageway and positioned relative to occluding anatomic structures. Upon deployment, the ribs along with web members extending between the ribs move outwardly from the central tube and press upon the tissues of the pharyngeal cavity. Spaces between the extended spokes permit the passage of air along the stent and maintain airway patency.

Abstract: A stent including hollow struts is formed on a cylindrical substrate. The struts of the stent are formed by electroforming metal layers of the strut in openings formed in a patterned photoresist material. A first metal layer forming the inner strut material is formed in openings in a first photoresist material. A sacrificial material to form the cavity to make the struts hollow is formed in openings in a second photoresist material. A second metal layer forming the side walls and outer wall of the struts is formed in openings in a third photoresist material and around the sacrificial material. The photoresist materials are removed. The substrate and cavity sacrificial material are removed, leaving hollow struts formed into a stent pattern. The hollow struts may be filled with a therapeutic substance for elution. Openings through the struts to the cavity may be formed during the forming process.

Abstract: The present invention relates to a gold-plated stent and its preparation method. More specifically, it relates to a gold-plated stent that is coated with various chemical materials such as 2-aminoalkanethiol, epihalogenhydrin, and diamine compounds in a sequence and also oligonucleotide gold-plated stent, which is prepared by binding oligonucleotide, a biomaterial, to the gold-plated stent coated with said chemicals. The oligonucleotide gold-plated stent of the present invention has an advantages of raising the local concentration in injured parts and minimizing the toxicity overall the body, so it can be used for prevention of restenosis after angioplasty.

Abstract: Disclosed is a flow control device for a bronchial passageway. The device can includes a valve member that regulates fluid flow through the flow control device, a frame coupled to the valve member, and a membrane attached to the frame. At least a portion of the flow control device forms a seal with the interior wall of the bronchial passageway when the flow control device is implanted in the bronchial passageway. The membrane forms a fluid pathway from the seal into the valve member to direct fluid flowing through the bronchial passageway into the valve member.

Abstract: Absorbable/disintegratable endourological stents, specifically endoureteral stents, and applicators for their introduction into the biological site, are formed from fiber-reinforced elastomeric films configured to prevent their migration from the application site.

Abstract: A portable negative pressure wound therapy system includes a dressing assembly for positioning over a wound to apply a negative pressure to the wound and a canister assembly. The canister assembly includes a control unit having a vacuum source and a controller and a collection canister in communication with the dressing assembly operable to receive fluid from the wound. The collection canister has a filter assembly having a filter and a passageway between the filter and a wall of the collection canister. The collection canister also includes a canister interface having a suction port, an inlet port, and a channel. The vacuum source draws air through the suction port from the channel which draws air from the passageway connected to the channel, the air in the passageway is drawn from the collection canister through the filter, and the air in the collection canister is drawn through the inlet port.

Abstract: A ureteral stent for assisting the movement of urine along a patient's ureter and into the patient's bladder. The stent includes an elongated tubular segment extending toward the bladder from a kidney end region for placement in the renal cavity to a bladder end region. A central lumen connects at least one opening at the first end region to at least one opening in the bladder end region. Thin flexible tail(s) are attached to the bladder end region of the tubular segment at a point outside the bladder so as to receive urine from the opening in the bladder end region of the tubular segment and to transport urine from there across the ureter/bladder junction and into the bladder. The tails include an elongated external urine-transport surface sized and configured to transport urine along the ureter. The urine transporting surface(s) are sized and configured to extend along at least part of the ureter, across the ureter/bladder junction, and from there into the bladder.

Abstract: A bioabsorable stent is disclosed. The stent is made of a bioabsorable material and has an elongated body having a proximate end, a distal end, and at least one open channel formed on the exterior surface of the elongated body to provide fluid communication between the proximal end and the distal end. Also disclosed is a bioabsorable stent having an elongated center rod having a proximate end and a distal end and a plurality of leaflets extending outward from the center rod and forming channels between two neighboring leaflets to provide fluid communication between the proximal end and the distal end.

Abstract: Ureteral stents having at least a portion of a proximal end of the ureteral stent constructed with a material that dissolves after being exposed to a bodily fluid for a period of time are disclosed herein. At least a portion of the proximal end portion of the elongate member includes a dissolving portion configured to dissolve in response to being exposed to a bodily fluid for a period of time. The elongate member also includes a non-dissolving portion that includes the entire retention member of the distal end portion and is substantially stable in the bodily fluid of the urinary tract of the patient. In some embodiments, a medial portion of the ureteral stent is also constructed with one or more dissolving materials. In some implementations, the proximal and/or the medial portions of the ureteral stent are constructed using various combinations of dissolving and non-dissolving materials.

Abstract: This invention relates to coating a surface wherein the coated surface inhibits foulants such as cell and/or protein and/or prion adhesion or formation. In particular, the coated surface may be part of a medical device which inhibits bacterial adhesion and colonisation, thrombus formation and/or prion, blood protein and/or protein formation.

Abstract: A method includes forming an elongated member having a tubular shape. The elongated member includes a sidewall that defines a lumen. A spiral-shaped opening is formed in the sidewall such that the elongated member is configured to move between a retracted configuration and an expanded configuration along a longitudinal axis of the lumen. In some embodiments, the method further includes forming a distal retention structure. The distal retention structure can be disposed at a distal end of the elongated member and can define a lumen in fluid communication with the lumen defined by the sidewall of the elongated member.

Abstract: According to an aspect of the present invention, the present invention provides medical devices which contain one or more polymeric regions that are at least partially biodisintegrable in bodily fluid. These devices may be implanted or inserted into a subject for treatment of various diseases, disorders and conditions.

Abstract: A device to facilitate insertion or threading of a flexible silicone intubation stent into the lacrimal drainage system of a patient. The device has an oblong hollow semi-rigid probe having the flexible stent releasably secured to its blunted distal end. The probe and stent are oriented in a side-by-side configuration and inserted endwise through the punctal opening, down through the nasolacrimal duct and into the nasal cavity. The flexible stent is detached from the distal end of the probe, and the probe withdrawn, leaving the stent in place. The flexible stent can be temporarily secured to the distal end of the probe through a number of means. One preferred way is to friction fit a resilient distal aperture of the stent upon the distal end of the probe and occlude the probe's distal opening. The stent is detached by injecting a pressurized fluid through the channel of the probe thereby forcing the distal end of the stent to pop off.

Abstract: A bioabsorable stent is disclosed. The stent is made of a bioabsorable material and has an elongated body having a proximate end, a distal end, and at least one open channel formed on the exterior surface of the elongated body to provide fluid communication between the proximal end and the distal end. Also disclosed is a bioabsorable stent having an elongated center rod having a proximate end and a distal end and a plurality of leaflets extending outward from the center rod and forming channels between two neighboring leaflets to provide fluid communication between the proximal end and the distal end.

Abstract: A stress reduction device and method includes positioning a device at the gastro-esophageal region of the patient. The device has a wall that is generally configured to the anatomy at the gastro-esophageal region of the patient. A strain is applied with the wall at the gastro-esophageal region, thereby increasing generation of at least one neuro-humoral transmitter.

Abstract: A new multiple component stent arrangement which allows for initial self-expansion and subsequent deformation to a final enlarged size.

Abstract: Disclosed is a pressure sensitive prosthesis that includes a tubular member having a passageway extending therethrough and a sleeve attached about one end of the tubular member. The sleeve functions as a one-way valve to permit fluid flowing through the sleeve lumen in a first, distal direction and under a first pressure, while collapsing in response to fluid flowing in a second direction when the pressure thereof exceeds that of the first direction or pressure. One aspect of the invention includes a first opening and a second opening configured for allowing fluid flow from the passage to the lumen in the first direction.

Abstract: A flexible shaft (28) to be inserted into a channel of a living body provided with a plurality of adjacently abutting cells (26), the walls (30) of which are formed from wall sections. For this reason the flexible shaft (28), which is particularly cost-effective to produce and which demonstrates high flexibility paired with ample stability, is constructed such that in at least one cell (26) in the cross-section of the wall (30) a concave wall section (44, 46, 48) is circumferentially alternated with a corresponding neighboring convex wall section (50, 52, 54).

Abstract: Therapeutic device intended for the selective cytoreductive treatment of an obstruction in a natural lumen or passage of the human or animal body, said lumen being obstructed by the effect of a local cell proliferation, said device comprising a tubular element, in particular of cylindrical shape, intended to be placed in said natural lumen and sufficiently flexible to conform to said natural lumen, but sufficiently rigid to maintain an artificial channel in said lumen. The tubular element supports lengthwise a medicinal sleeve which is intended to come into line with, and into contact with, the obstruction once the natural lumen has been intubated, and is designed to deliver locally, at least in its outer surface portion, at least one therapeutic agent which is cytoreductive, in particular cytotoxic, through contact with the cells under whose effect said lumen is obstructed.

Abstract: The invention relates to a mechanical piece having a structure comprising a substrate (1) and at least one surface coating layer (3) of nanometric thickness, for improving mechanical resistance, characterized in that it comprises between the substrate and the surface coating layer an essentially non ceramic, non porous adhesion layer of nanometric size; and said surface coating layer is an essentially non porous barrier layer (2) consisting essentially of an essentially stoechiometric titanium nitride layer.

Abstract: Devices are provided for insertion into a Eustachian tube of an animal, e.g., a human being. The devices include an insertable member. The member has opposing surfaces and is formed at least in part from a biocompatible material that is degradable. The device may comprise a hole that is effective to provide sufficient fluid communication between the opposing surfaces of the insertable member to effect pressure equilibration therebetween. The device is able to be immobilized within the Eustachian tube for a predetermined period. Also provided are kits that include the device and methods for inserting the device into a Eustachian tube.

Abstract: This invention relates to a fixing apparatus for fixing an apnea stent in the respiratory duct, the fixing apparatus (10) having a fixing device which can be fixed to a proximal end (2) of the apnea stent (1). The fixing apparatus distinguishes itself in that the fixing device has two clamping members (11, 12) between which the proximal end (2) of the apnea stent (1) can be fixed. This invention also relates to a joining member for connecting an apnea stent (1) and an insertion bar (5), a cleaning tube for receiving an apnea stent and a system for splinting the respiratory duct, comprising an apnea stent and a fixing apparatus.

Abstract: A ureteral stent comprising a short renal coil made of a pliable material and a wick portion made of a material having a hydrophilicity or hydrophobicity different from that of the renal coil and extending from a ureteropelvic junction to a bladder so as to assist in the transfer of urine out of a kidney and into the bladder and to improve patient comfort. Due to increased hydrophilicity or hydrophobicity, wick may be significantly smaller in diameter than renal coil, resulting in less reflux of urine into the kidney and further decreasing patient discomfort. The stent may further comprise one or more couplers between the renal coil and wick portion, and the wick portion may comprise a sheath surrounding an elastic core to prevent kinking and enhance the ability of the wick portion to move with the patient. A method of ureteral stent placement is also disclosed.

Abstract: A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.

Abstract: Disclosed is an intraluminal gastrointestinal (GI) device that is placed at the time of surgery to protect a freshly constructed GI anastomosis, GI staple-line, or the like. For the esophagus and stomach, the device covers the esophagus, stomach, and anastomosis/staple-line. For the pancreas or biliary duct, the device covers the biliary duct, pancreatic duct, and small bowel. For the colon and rectum, the device is a self expanding protective barrier that covers the anal canal, the anus, and the colon or rectum, approximately 18 cm proximal to the anus. These devices provide a waterproof barrier between the gastrointestinal content and the mucosa of the GI tract and the newly constructed anastomosis. Additionally, the design of the device is made to prevent migration within the gastrointestinal tract and facilitate removal of the device.

Abstract: A medical device for releasing in a hollow organ having a hollow cylindrical body that can be transferred in a compressed state having a reduced diameter and in an expanded state having an enlarged diameter. The body having a stop means at the proximal and/or distal axial end thereof having at least one retaining element connected to the body by a connecting segment. The retaining element and the body are decoupled by the connecting segment such that the retaining element has a smaller curvature in the compressed state than the body. The connecting segment elastically connects the retaining element and the body, wherein the contour of the retaining element in the compressed state of the body protrudes past the outer circumference of the body such that the retaining element is displaceable radially inward relative to the body into a stop position through the inner wall of an insertion system.

Abstract: Method and apparatus for limiting absorption of food products in specific parts of the digestive system is presented. A gastrointestinal implant device is anchored in the stomach and extends beyond the ligament of Treitz. All food exiting the stomach is funneled through the device. The gastrointestinal device includes an anchor for anchoring the device to the stomach and a flexible sleeve. When implanted within the intestine, the sleeve can limit the absorption of nutrients, delay the mixing of chyme with digestive enzymes, altering hormonal triggers, providing negative feedback, and combinations thereof. The anchor is collapsible for endoscopic delivery and removal.

Abstract: In one embodiment, a medical device includes an elongated member having a sidewall defining a lumen. The lumen extends through the member and defines a center line which extends through a center of the lumen in a direction longitudinal to the member. The sidewall defines a plurality of slots. Each successive slot is circumferentially offset about the sidewall. In another embodiment, a medical device includes a member defining a lumen extending through the member. Locations of an outer surface of the member are defined by a distance d from a proximal end of the member and an angle ? from a first point of a cross-section of the member. A sidewall of the member includes slots extending through the sidewall along planes extending from a line extending through a center of the lumen. Successive slots have their respective distances d successively farther from the proximal end of the member and their respective angles ? successively increasing.

Abstract: A drainage stent delivery system including a stent, a guide catheter, a push catheter, and an outer sheath. The guide catheter extends through the lumen of the stent and the push catheter is disposed over a portion of the guide catheter proximal of the distal end of the stent. The outer sheath is slidably disposed over the push catheter and surrounding at least a portion of the stent. The outer sheath may be actuated from a first position in which a distal portion of the outer sheath surrounds the stent to a second position in which the distal portion of the outer sheath is proximal of the stent. The stent delivery system may also include a retention mechanism for selectively coupling the stent to the outer sheath which may selectively decouple the stent from the outer sheath through rotational and/or translational motion of the outer sheath relative to the stent.

Abstract: A radiation and radiochemically sterilized, multi-component, fiber-reinforced composite, absorbable/disintegratable urinogenital stent, such as an endoureteral stent, with radiomodulated residence time in the biological site of 1 to 10 weeks depending on the high energy radiation dose used for sterilization.

Abstract: A system, device and method for dilating an anatomical structure. Systems, devices and methods may comprise a therapeutic component configured to treat a paranasal sinus. Specific embodiments may use high frequency pressure waves and/or cryogenic temperatures.

Abstract: Stents, kits and methods of using the stents are described herein. The stents may include one or more features that assist in removal and/or retrieval of the stent after deployment.

Abstract: Method and apparatus for limiting absorption of food products in specific parts of the digestive system is presented. A gastrointestinal implant device is anchored in the stomach and extends beyond the ligament of Treitz. All food exiting the stomach is funneled through the device. The gastrointestinal device includes an anchor for anchoring the device to the stomach and a flexible sleeve. When implanted within the intestine, the sleeve can limit the absorption of nutrients, delay the mixing of chyme with digestive enzymes, altering hormonal triggers, providing negative feedback, and combinations thereof. The anchor is collapsible for endoscopic delivery and removal.

Abstract: An apparatus for cleansing and applying therapy or prophylaxis to wounds, in which irrigant fluid containing a physiologically active material from a reservoir connected to a conformable wound dressing and wound exudate from the dressing are recirculated by a device for moving fluid through a flow path which passes through the dressing and a means for fluid cleansing and back to the dressing. A biodegradable scaffold underlies the dressing on the wound bed to promote tissue growth. The cleansing means (which may be a single-phase, e.g. micro-filtration, system or a two-phase, e.g. dialytic system) removes materials deleterious to wound healing, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned to the wound bed. The dressing, an assembly comprising the dressing and scaffold, and a method of treatment using the apparatus.

Abstract: The present invention provides modified metal surfaces, methods of preparing the same, and intermediates thereto. These materials are useful in a variety of applications including biomaterials.

Abstract: A method of treatment of sinusitis and other related diseases including disposing a radially expandable stent into a nasal passageway and radially expanding the stent in a blocked region of the nasal passageway to expand the blocked region is disclosed. The stent includes a tissue-cushioning portion composed of a hydrogel-forming or elastomeric polymer material to provide cushioning between the stent and nasal tissue and reduce irritation of the nasal tissue.

Abstract: Provided is a stent to be inserted into an in vivo organ having a tubular structure that allows a degree of freedom in design and excellent mechanical flexibility. A cylinder-shaped stent is inserted to be placed and used in the inner cavity of an in vivo tubular organ, wherein: the wall of the stent has a planar mesh pattern filled with a plurality of closed cells being adjacent to each other and having congruent shapes; the closed cells have point-symmetric parallel hexagonal shapes; all closed cells circumferentially adjacent to each other are congruent and similar in shape; two closed cells adjacent to each other sharing different sides form a substantially V-shaped member; and the vertex of each folded part in the substantially V-shaped member points to the circumferential direction.

Abstract: Disclosed herein are devices, methods and kits for a stent for treating an eye, comprising a flexible material, wherein the stent is self adaptive to a dimension of a vitreous cavity in the eye.

Abstract: In one embodiment, a surgical device includes a stent deployment device that includes a stent, a dilator, and a cutting element that can be selectively extended from and retracted into the surgical device. In some embodiments, the surgical device can be used to implant a stent in a patient by passing the surgical device through a natural orifice of the patient, accessing the peritoneal cavity with the surgical device, translumenally accessing the lumen of the small intestine with the surgical device, passing a stent deployment device into the lumen with the surgical device, and expanding the stent within the lumen using the surgical device. In other embodiments, the surgical device can be used to perform endoscopic translumenal pancreatic pseudocyst drainage.

Abstract: Provided herein are a method, which comprises implanting in a patient an implantable device comprising a coating that includes a PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid biocompatible polymer and the methods of use thereof.

Abstract: An elongate medical device configured for at least partial implantation or insertion into a subject. The medical device has at least one surface that contains one or more depressions, which are at least partially filled with a soluble material. Also described methods of making such devices.

Abstract: A ureteral stent is designed to be placed within a patient's ureter to facilitate drainage from the patient's kidneys to the bladder. An elongated portion of the stent includes a length sufficient to extend substantially within the ureter from the kidney to the bladder, and the elongated portion defines a lumen extending therethrough. A retention portion extends from one end of the elongated portion and retains the position of the ureteral stent when placed substantially within the kidney. The retention portion includes an interior space that is in communication with the lumen within the elongated portion and has at least one opening for urine drainage. A flared portion extending from the other end of the elongated portion is positioned within the patient's bladder. The flared portion curves outward and includes an elastic member that maintains the shape of the flared portion when positioned within the bladder.

Abstract: A radiation and radiochemically sterilized, multi-component, fiber-reinforced composite, absorbable/disintegratable urinogenital stent, such as an endoureteral stent, with radiomodulated residence time in the biological site of 1 to 10 weeks depending on the high energy radiation dose used for sterilization.

Abstract: This invention deals with an absorbable/disintegratable endo-urological stent and applicators for introduction into biological conduits, including such as urethras and ureters, with said stent comprising a fiber-reinforced, multicomponent tube made of polyesters having a range of physicochemical properties.

Abstract: A urological repair device includes a stent having a diameter that fits within a portion of a urological structure. The stent also has a length to bridge a distance between a first end of the urological structure and a second end of the urological structure. The stent includes at least one tapered end. The tapered end enables placement of the stent within the urological structure. A method of repairing a urological structure includes placing a first end of a substantially tubular urological structure over a first end of a tubular stent, and placing a second end of a substantially tubular urological structure over a second end of a stent, and attaching the first end of the substantially tubular urological structure, the second end of a substantially tubular urological structure, and the tubular stent to form a fluid passageway.

Abstract: A stent for repairing post-anastomasis (e.g., bariatric) surgery leaks is formed by an elongated tube having a proximal flare-shaped flange, an enlarged middle section, and a distal flare-shaped flange, where an exterior surface of the elongated tube is substantially covered with a polymer.

Abstract: Apparatus for accessing a bodily passageway, the apparatus comprising: a flexible tube having a distal end and a proximal end, a longitudinal axis extending between the distal end and the proximal end, and a lumen extending from the distal end to the proximal end, the lumen being sized to receive matter to be transported through the bodily passageway; and an external thread disposed over the distal end of the tube, the external thread having a sufficient structural integrity, and a sufficient surface profile, such that when the tube is disposed in a bodily passageway, rotation of the tube about the longitudinal axis will result in longitudinal motion of the tube along said bodily passageway.

Abstract: The present invention is an endo-prostatic stent and a detachable catheter apparatus including the same, allowing the correct positioning of the stent using tactile feed-back of the operator during insertion i.e. without the need for any imaging means like endoscopy or sonography.